secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHINA PHARMA HOLDINGS, INC. (CPHI)
CIK:        0001106644
Form:       8-K
Filed at:   2023-04-20T23:59:59+00:00
Accession:  0001213900-23-031309
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

China Pharma Holdings extends convertible note maturity to May 2024 with Streeterville Capital
--------------------------------------------------------------------------------

- Maturity extended from November 2021 note to May 19, 2024, with an extension fee of 2% of the outstanding balance.
- Outstanding balance as of April 12, 2023 was $3,281,970.19; original note principal was $5,250,000.
- Conversion price reduced to 82% multiplied by the lowest VWAP during the prior 10 trading days.
- New monthly redemption minimum of $150,000; failure to meet triggers a 1% penalty increase to outstanding balance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1106644/000121390023031309/0001213900-23-031309-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1106644/000121390023031309/ea177239-8k_chinapharm.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-031309

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer